SignalFDA/Bio

Intellia Eyes Lonvo-z Launch as HAE PDUFA Nears, TTR Study Advances

Intellia advancing lonvo-z toward HAE PDUFA and TTR study progress drives biotech catalyst interest.

What changed

Intellia advancing lonvo-z toward HAE PDUFA and TTR study progress drives biotech catalyst interest.

Why it matters

Intellia advancing lonvo-z toward HAE PDUFA and TTR study progress drives biotech catalyst interest. — impact context not separately stored; see What changed.

Sources

eodhd